Patents by Inventor Lihong Hu

Lihong Hu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8168647
    Abstract: The invention provides vinblastine derivatives represented by the following formula 1 or their physiologically acceptable salts, their preparation, use and pharmaceutical compositions comprising the said derivatives. The said vinblastine derivatives show inhibiting activities against tumor cell lines and can be used as medicaments for treating malignant tumors.
    Type: Grant
    Filed: December 17, 2007
    Date of Patent: May 1, 2012
    Assignee: Shanghai Institute of Materia Medica Chinese Academy of Sciences
    Inventors: Lihong Hu, Xu Shen, Hualiang Jiang, Liguang Lou, Hong Ding, Yong Shao, Hankun Zhang
  • Publication number: 20110308641
    Abstract: An electronic intelligent touch control water faucet and an intelligent water supply central processor which includes a main body, an upper cover, an electromagnetic valve group, a temperature control and flow control member, a PCB control panel and an operation panel. The main body includes receiving troughs, two water inlet tubes and a water outlet tube communicated through pipes. The temperature control member includes a temperature control valve, a synchronous motor, and a temperature sensor. The temperature control valve communicates with the water inlet tubes and is driven and adjusted by the synchronous motor. PCB control panel controls the synchronous motor. The temperature sensor communicates the outlet water temperature to the PCB control panel. The flow control member includes a flow valve and a motor. The PCB control panel controls the motor driving the flow valve. The flow valve water outlet is connected to the water outlet tube.
    Type: Application
    Filed: May 5, 2009
    Publication date: December 22, 2011
    Inventors: Lihong Hu, Dengliang Tong
  • Publication number: 20100113494
    Abstract: The present invention provides 13,13a-dihydroberberine derivatives or their physiologically acceptable salts represented by the following formula, pharmaceutical compositions comprising the same, and uses thereof. The 13,13a-dihydroberberine derivatives have an activity of promoting glucose absorption in muscle cells, and the whole animal tests show that the present compounds have effects on improving glucose-tolerance and insulin-resistance, facilitating weight loss, relieving fatty liver and the like. Thus, the present compounds can be used in treating diabetes mellitus, adiposity, fatty liver and complications thereof induced by insulin resistance.
    Type: Application
    Filed: September 30, 2007
    Publication date: May 6, 2010
    Applicant: SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
    Inventors: Lihong Hu, Jia Li, Jingya Li, Hankun Zhang, Zhe Cheng, Jiming Ye, David E. James, Edward W. Kraegen
  • Publication number: 20100113498
    Abstract: The invention provides vinblastine derivatives represented by the following formula 1 or their physiologically acceptable salts, their preparation, use and pharmaceutical compositions comprising the said derivatives. The said vinblastine derivatives show inhibiting activities against tumor cell lines and can be used as medicaments for treating malignant tumors.
    Type: Application
    Filed: December 17, 2007
    Publication date: May 6, 2010
    Applicant: Shanghai Institute of Materia Medica, Chinese Academy of Sciences
    Inventors: Lihong Hu, Xu Shen, Hualiang Jiang, Liguang Lou